Personalis Quick Ratio 2018-2025 | PSNL
Historical quick ratio values for Personalis (PSNL) over the last 10 years.
| Personalis Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2025-03-31 |
$0.20B |
$0.03B |
6.74 |
| 2024-12-31 |
$0.20B |
$0.03B |
6.33 |
| 2024-09-30 |
$0.16B |
$0.04B |
4.44 |
| 2024-06-30 |
$0.10B |
$0.03B |
3.05 |
| 2024-03-31 |
$0.11B |
$0.03B |
3.56 |
| 2023-12-31 |
$0.14B |
$0.05B |
2.89 |
| 2023-09-30 |
$0.14B |
$0.03B |
4.31 |
| 2023-06-30 |
$0.15B |
$0.03B |
5.35 |
| 2023-03-31 |
$0.18B |
$0.03B |
5.11 |
| 2022-12-31 |
$0.19B |
$0.03B |
5.77 |
| 2022-09-30 |
$0.21B |
$0.03B |
6.35 |
| 2022-06-30 |
$0.25B |
$0.04B |
6.08 |
| 2022-03-31 |
$0.29B |
$0.04B |
7.18 |
| 2021-12-31 |
$0.31B |
$0.03B |
9.98 |
| 2021-09-30 |
$0.32B |
$0.03B |
12.20 |
| 2021-06-30 |
$0.35B |
$0.03B |
10.18 |
| 2021-03-31 |
$0.37B |
$0.04B |
9.52 |
| 2020-12-31 |
$0.22B |
$0.04B |
5.29 |
| 2020-09-30 |
$0.22B |
$0.04B |
6.05 |
| 2020-06-30 |
$0.11B |
$0.04B |
2.64 |
| 2020-03-31 |
$0.13B |
$0.05B |
2.48 |
| 2019-12-31 |
$0.14B |
$0.05B |
2.70 |
| 2019-09-30 |
$0.14B |
$0.05B |
2.86 |
| 2019-06-30 |
$0.17B |
$0.06B |
3.06 |
| 2019-03-31 |
$0.00B |
|
0.00 |
| 2018-12-31 |
$0.00B |
|
0.00 |
| 2018-09-30 |
$0.00B |
|
0.00 |
| 2018-06-30 |
$0.00B |
|
0.00 |
| 2017-12-31 |
$0.00B |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.414B |
$0.085B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
